Antibiotics Associated with Stevens-Johnson Syndrome
Trimethoprim-sulfamethoxazole (TMP-SMX) carries the highest risk for Stevens-Johnson syndrome among antibiotics, followed by sulfonamides, beta-lactams (particularly amoxicillin-clavulanate), fluoroquinolones, cephalosporins, tetracyclines, macrolides, and vancomycin.
High-Risk Antibiotic Categories
Sulfonamides - Highest Risk
- TMP-SMX represents the most notorious antibiotic for causing SJS/TEN 1, 2, 3, 4
- The crude relative risk is substantially elevated at 172 in some populations 1
- Risk is particularly elevated in HIV-positive patients 1
- Sulfamethoxazole demonstrated the highest risk signal in recent pharmacovigilance analysis of 78,593 infected patients 4
Beta-Lactams - High Risk
Penicillins:
- Amoxicillin shows significant risk association with SJS/TEN 4, 5
- Amoxicillin-clavulanate (co-amoxiclav) is well-documented as a cause, even in patients with prior uneventful exposures 5
- Piperacillin demonstrates positive risk signals 4
Cephalosporins:
- Ceftriaxone, cefuroxime, and cefotaxime all show significant risk associations 4
- These are commonly implicated in pediatric populations 3
Fluoroquinolones - Moderate to High Risk
- Account for approximately 4% of SJS/TEN cases 6
- Levofloxacin specifically documented in fatal cases, particularly in oncologically complex patients 6
- Risk appears elevated in patients with hypoalbuminemia and advanced malignancy 6
Tetracyclines - Moderate Risk
- Doxycycline and minocycline both show significant risk associations 4
- Minocycline has been associated with more serious adverse events compared to other tetracyclines (8.8 cases per 100,000 patient-years) 1
- Minocycline specifically linked to drug-induced lupus and DRESS syndrome 1
Macrolides - Moderate Risk
- Azithromycin demonstrates positive risk signals 4, 7
- Cases documented even in patients with concurrent SARS-CoV-2 infection 7
- Erythromycin, clarithromycin also implicated 3
Glycopeptides
- Vancomycin shows significant risk association in pharmacovigilance data 4
Aminoglycosides
- Gentamicin demonstrates positive risk signals 4
High-Risk Patient Populations
Patients at elevated risk include:
- Those with pneumonia, urinary tract infections, or sepsis (higher risk than respiratory tract infections) 4
- Male patients may have higher risk than females with certain antibiotics 4
- Oncologically complex patients, particularly those with advanced colorectal cancer, malignant ascites, and hypoalbuminemia 6
- HIV-positive patients (especially with TMP-SMX) 1
- Patients with end-stage renal disease 7
- Pediatric patients (infections and drugs both important triggers) 3
Critical Clinical Considerations
Immediate action required:
- Withdraw the suspected antibiotic immediately upon recognition - this decreases risk of death 3
- Immediate discontinuation is mandatory if any sign of bullous or exfoliative skin rash develops 8
Timing of onset:
- Most reactions occur within 8 days of drug initiation 6
- Delayed-onset cases can occur even in elderly patients with prior uneventful exposures 5
Genetic susceptibility:
- HLA-B*1502 testing recommended for South East Asian patients before carbamazepine (anticonvulsant, not antibiotic) 3
- Consider genetic testing for severe cases where drug avoidance is medically compromising 3
Common Pitfalls to Avoid
Do not dismiss prior safe exposures - patients can develop SJS/TEN even after multiple uneventful courses of the same antibiotic 5
Do not confuse paracetamol/ibuprofen as causative - these are likely confounders given frequent use for prodromal symptoms, though rare reports exist 3
Do not overlook infection as trigger - up to 50% of pediatric SJS/TEN cases are infection-induced (HSV, Mycoplasma pneumoniae) 3
Do not delay specialist referral - delayed transfer to specialist units increases mortality 2